Development of Chitosan/Cyclodextrins in Drug Delivery Field

Dear Colleagues,

Chitosan, as well as cyclodextrins, are among the most abundant and widespread carbohydrate biomolecules in nature. They are a class of substances with a long history in drug delivery and have attracted increasing attention in recent years. Chitosan is a polysaccharide derived by the deacetylation of the naturally occurring polymer chitin. Due to its excellent biocompatibility, biodegradability, lack of allergenicity, and antibacterial activity, chitosan has been widely used in drug delivery systems for nearly every route of administration, including biomaterials for tissue-engineered scaffolds and wound dressings. On the other hand, the well-known use of cyclodextrins in pharmaceuticals is due to their effective complexing capacity to increase the solubility and bioavailability of poorly water-soluble drugs. Despite a significant quantity of research and an equal amount of commercial products, chitosan and cyclodextrins continue to be of interest to both the academic and industrial communities, and there is no doubt that further advancements and uses will be made in the future.

We are pleased to invite you to contribute to this Special Issue titled "Development of Chitosan/Cyclodextrins in Drug Delivery Field". This Special Issue welcomes original research articles and reviews that cover all aspects of the design, manufacturing, characterization, and final formulation of chitosan/cyclodextrin-based drug delivery systems, but other themes not limited to this are welcomed.

We look forward to receiving your contributions.

Dr. Magdalena Paczkowska-Walendowska
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.